EUVIMEDEUVIMED entdecken
Crossref

Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis

Elena Díaz-García iD, David Sanz-Rubio, Sara García-Tovar, Enrique Alfaro, Pablo Cubero, Ana V Gil, José M Marin, Carolina Cubillos-Zapata, Francisco García-Río iD

European Respiratory Journal · 2023-03 · 61 (3) · 2201401

DOI: 10.1183/13993003.01401-2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 14.12.2022. Verfasst von Elena Díaz-García und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. Hauptthemen laut MEDLINE: Atherosclerosis, Sleep Apnea, Obstructive, Dyslipidemias. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Fondo de Investigación Sanitaria-Fondos FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atherosclerosis is a common comorbidity of obstructive sleep apnoea (OSA) patients, caused by the interaction of dyslipidaemia and systemic inflammation. The OSA pro-inflammatory response is mediated by NLRP3 inflammasome activation, which requires a priming signal mediated by intermittent hypoxia (IH) and an activation signal provided by soluble stimulus present in plasma. Our objectives were to study oxidised low-density lipoprotein (oxLDL) expression in OSA patients with or without early subclinical atherosclerosis (eSA) as well as its contribution to NLRP3 activation and tissue factor (TF) release.

Methods

We analysed oxLDL, key components of the NLRP3 inflammasome cascade and TF in plasma and monocytes from OSA patients and non-apnoeic subjects, with or without eSA as determined by increased carotid intima–media thickness without the appearance of atherosclerotic plaques. The oxLDL contribution to NLRP3 inflammasome activation was assessed using in vitro models.

Results

High levels of oxLDL were identified in plasma from OSA patients, particularly in those with eSA, as well as an overexpression of NLRP3 cascade components and TF. Furthermore, in vitro models showed that both oxLDL and plasma from OSA patients with eSA act synergistically with IH as a priming and activation signal of NLRP3 that enhances the inflammatory response, pyroptosis and TF release.

Conclusions

OSA patients with eSA exhibit NLRP3 activation by IH and the presence of oxLDL capable of releasing TF, constituting a pathway for the interaction between dyslipidaemia and systemic inflammation in the development of atherosclerotic lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisSleep Apnea, ObstructiveDyslipidemiasHumansInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinCarotid Intima-Media ThicknessLipoproteins, LDLInflammation

Substanzen

Inflammasomesoxidized low density lipoproteinNLR Family, Pyrin Domain-Containing 3 ProteinLipoproteins, LDL

Autor:innen und Institutionen

  • Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
  • Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Translational Research Unit, Miguel Servet University Hospital - IISAragon, Zaragoza, Spain.
  • Department of Medicine, University of Zaragoza School of Medicine, Zaragoza, Spain.
  • Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain cubilloszapata@gmail.com.
  • C. Cubillos-Zapata and F. García-Río contributed equally to this article as lead authors and supervised the work.

ORCID-Profile: Elena Díaz-García, Francisco García-Río

Förderung

  • Fondo de Investigación Sanitaria-Fondos FEDER

Zitieren

APA

Díaz-García, E., Sanz-Rubio, D., García-Tovar, S., Alfaro, E., Cubero, P., Gil, A. V., Marin, J. M., Cubillos-Zapata, C., & García-Río, F. (2023). Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis. European Respiratory Journal, 61(3), 2201401. https://doi.org/10.1183/13993003.01401-2022

Vancouver

Díaz-García E, Sanz-Rubio D, García-Tovar S, Alfaro E, Cubero P, Gil AV, et al. Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis. European Respiratory Journal. 2023;61(3):2201401. doi:10.1183/13993003.01401-2022

BibTeX
@article{DazGarca2023,
  author = {Díaz-García, Elena and Sanz-Rubio, David and García-Tovar, Sara and Alfaro, Enrique and Cubero, Pablo and Gil, Ana V and Marin, José M and Cubillos-Zapata, Carolina and García-Río, Francisco},
  title = {Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis},
  journal = {European Respiratory Journal},
  year = {2023},
  volume = {61},
  number = {3},
  pages = {2201401},
  doi = {10.1183/13993003.01401-2022}
}
Kostenlos starten →